A universal combinatorial design of antibody framework to graft distinct CDR sequences: A bioinformatics approach

Authors

  • Jaafar N. Haidar,

    1. Department of Antibody Technology, ImClone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company, Alexandria Center for Life Sciences, New York, New York
    Search for more papers by this author
  • Qing-An Yuan,

    1. Department of Antibody Technology, ImClone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company, Alexandria Center for Life Sciences, New York, New York
    Search for more papers by this author
  • Lin Zeng,

    1. Department of Antibody Technology, ImClone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company, Alexandria Center for Life Sciences, New York, New York
    Search for more papers by this author
  • Mark Snavely,

    1. Department of Antibody Technology, ImClone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company, Alexandria Center for Life Sciences, New York, New York
    Search for more papers by this author
  • Xenia Luna,

    1. Department of Antibody Technology, ImClone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company, Alexandria Center for Life Sciences, New York, New York
    Search for more papers by this author
  • Haifan Zhang,

    1. Department of Antibody Technology, ImClone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company, Alexandria Center for Life Sciences, New York, New York
    Search for more papers by this author
  • Wei Zhu,

    1. Department of Antibody Technology, ImClone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company, Alexandria Center for Life Sciences, New York, New York
    Search for more papers by this author
  • Dale L. Ludwig,

    1. Department of Antibody Technology, ImClone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company, Alexandria Center for Life Sciences, New York, New York
    Search for more papers by this author
  • Zhenping Zhu

    1. Department of Antibody Technology, ImClone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company, Alexandria Center for Life Sciences, New York, New York
    Search for more papers by this author

Errata

This article corrects:

  1. A universal combinatorial design of antibody framework to graft distinct CDR sequences: A bioinformatics approach Volume 80, Issue 3, 896–912, Article first published online: 16 December 2011

Correspondence to: Jaafar N. Haidar. E-mail: jaafar.haidar@imclone.com

No abstract is available for this article.

Ancillary